| Name | Title | Contact Details |
|---|
Since 1968 our goal has been straightforward: help patients get their life back on track and achieve a life of sobriety, free from drug use and symptoms of mental illness. A life that is productive, socially responsible and healthy. Gateway Foundation is one of the nation`s largest nonprofit provider of substance use disorder treatment and a nationally recognized leader in the field of addiction medicine. With treatment programs in Florida, Georgia, Illinois, Michigan, Missouri, New Jersey, Texas and Wyoming we specialize in substance use disorders for patients diagnosed with substance use disorder and mental health disorders. Gateway Foundation`s professional clinicians support over 9,000 people a day to successfully complete treatment by developing a personalized plan to treat the underlying causes of substance use disorder—not just their addiction to drugs or alcohol.
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
Healthcare Informatics Associates is a Bainbridge Island, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
LakeWood Health Center consists of the following four divisions: care center, clinic, hospital, and public health.. They service a population of 6,000 to 9,000 people, the number fluctuating with seasonal tourism activities. LakeWood is a federally designated Critical Access Hospital. As a Catholic non-profit organization, LakeWood Health Center is located in Baudette, Minnesota, and is owned and operated by Catholic Health Initiatives of Denver, Colorado. Our staff serve the social, health and welfare needs of the residents in Lake of the Woods County; contiguous counties, Koochiching, Beltrami, and Roseau; and neighboring Canada.
MedPro Safety Products is a Lexington, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.